Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
TPX-0022 inhibits Met, Csf1r, and Src, which may lead to growth inhibition in tumor cells (Proceedings of the American Association for Cancer Research, Vol 60, Mar 2019, Abstract #1321).
|DrugClasses||CSF1R Inhibitor 24 MET Inhibitor 51 SRC Inhibitor 29|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|